ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 169 filers reported holding ALKERMES PLC in Q2 2020. The put-call ratio across all filers is 2.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,436,214 | +41.3% | 192,842 | +31.0% | 0.05% | +62.5% |
| Q4 2022 | $3,846,022 | -26.4% | 147,188 | -37.1% | 0.03% | -27.3% |
| Q3 2022 | $5,224,000 | -48.1% | 233,911 | -30.7% | 0.04% | -55.1% |
| Q2 2022 | $10,058,000 | +228.0% | 337,608 | +189.7% | 0.10% | +250.0% |
| Q1 2022 | $3,066,000 | +682.1% | 116,540 | +817.6% | 0.03% | +600.0% |
| Q3 2021 | $392,000 | -86.6% | 12,700 | -89.3% | 0.00% | -87.1% |
| Q2 2021 | $2,916,000 | -44.5% | 118,902 | -54.9% | 0.03% | -56.3% |
| Q4 2020 | $5,258,000 | +1377.0% | 263,582 | +967.7% | 0.07% | +222.7% |
| Q1 2020 | $356,000 | -50.6% | 24,688 | -22.8% | 0.02% | -12.0% |
| Q2 2019 | $721,000 | +38.4% | 32,000 | +124.1% | 0.02% | +38.9% |
| Q1 2019 | $521,000 | -2.4% | 14,279 | -21.1% | 0.02% | -14.3% |
| Q4 2018 | $534,000 | +29.9% | 18,100 | +155.2% | 0.02% | -50.0% |
| Q2 2017 | $411,000 | – | 7,093 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
| Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
| Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
| Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
| First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
| Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
| PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
| Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |